A Practical Guide for Calculating Indirect Costs of Disease
- 78 Downloads
There may be some discussion about whether indirect costs should be taken into account at all in an economic appraisal, but there is certainly considerable debate about the proper way of estimating these costs.
This reviews offers a practical guide for quantifying and valuing these indirect costs of disease, both at an aggregated level of general cost of illness studies, and in an economic appraisal of specific healthcare programmes.
Two methods of calculating these costs are considered: the traditional human capital approach, and the more recently developed friction cost method. The former method estimates the potential value of lost production as a result of disease, whereas the latter method intends to derive more realistic estimates of indirect costs, taking into account the degree of scarcity of labour in the economy. All necessary steps in the estimation procedure and the data required at various points will be described and discussed in detail.
KeywordsIndirect Cost Production Loss Human Capital Approach Pharmaceutical Benefit Advisory Committee Economic Appraisal
Unable to display preview. Download preview PDF.
- 1.Draft guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee: including submissions involving economic analyses. Canberra: Commonwealth of Australia, 1995Google Scholar
- 2.Guidelines for economic evaluation of pharmaceuticals. 1st ed. Ottawa, Canada: CCOHTA, 1994Google Scholar
- 7.Lindgren B. Costs of illness in Sweden 1964–1975. Lund: Liber, 1981Google Scholar
- 9.de Koning J, Tuyl FAWM. The relation between labour time, production and employment [In Dutch]. Rotterdam: Netherlands Economic Institute, 1984Google Scholar
- 10.van Roijen L, Essink-Bot ML, Koopmanschap MA, et al. Labour and health status in economic evaluation of health care: the health and labour questionnaire. Int J Technol Assess Health Care. In pressGoogle Scholar